BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cutone A, Ianiro G, Lepanto MS, Rosa L, Valenti P, Bonaccorsi di Patti MC, Musci G. Lactoferrin in the Prevention and Treatment of Intestinal Inflammatory Pathologies Associated with Colorectal Cancer Development. Cancers (Basel) 2020;12:E3806. [PMID: 33348646 DOI: 10.3390/cancers12123806] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Hussain F, Rahim K, Ur Rehman S, Shafqat F, Siddique A, Ahsan M, Shuaib M, Khan IU, Shanyuan C. Lactoferrin and SARS-CoV-2. Application of Natural Products in SARS-CoV-2 2023. [DOI: 10.1016/b978-0-323-95047-3.00016-2] [Reference Citation Analysis]
2 Li C, Liu X, Huang Z, Zhai Y, Li H, Wu J. Lactoferrin Alleviates Lipopolysaccharide-Induced Infantile Intestinal Immune Barrier Damage by Regulating an ELAVL1-Related Signaling Pathway. IJMS 2022;23:13719. [DOI: 10.3390/ijms232213719] [Reference Citation Analysis]
3 Gonzalez-obeso C, Jane Hartzell E, Albert Scheel R, Kaplan DL. Delivering on the promise of recombinant silk-inspired proteins for drug delivery. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114622] [Reference Citation Analysis]
4 Xu S, Yang Q, Wang R, Tian C, Ji Y, Tan H, Zhao P, Kaplan DL, Wang F, Xia Q. Genetically engineered pH-responsive silk sericin nanospheres with efficient therapeutic effect on ulcerative colitis. Acta Biomater 2022;144:81-95. [PMID: 35288310 DOI: 10.1016/j.actbio.2022.03.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Insuasti-Cruz E, Suárez-Jaramillo V, Mena Urresta KA, Pila-Varela KO, Fiallos-Ayala X, Dahoumane SA, Alexis F. Natural Biomaterials from Biodiversity for Healthcare Applications. Adv Healthc Mater 2022;11:e2101389. [PMID: 34643331 DOI: 10.1002/adhm.202101389] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Liu N, Feng G, Zhang X, Hu Q, Sun S, Sun J, Sun Y, Wang R, Zhang Y, Wang P, Li Y. The Functional Role of Lactoferrin in Intestine Mucosal Immune System and Inflammatory Bowel Disease. Front Nutr 2021;8:759507. [PMID: 34901112 DOI: 10.3389/fnut.2021.759507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zheng JQ, Lin CH, Lee HH, Wang WK, Tong YS, Lee KY, Chiu HW, Lin YF. Lactotransferrin Downregulation Serves as a Potential Predictor for the Therapeutic Effectiveness of mTOR Inhibitors in the Metastatic Clear Cell Renal Cell Carcinoma without PTEN Mutation. Biomedicines 2021;9:1896. [PMID: 34944711 DOI: 10.3390/biomedicines9121896] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Algahtani FD, Elabbasy MT, Samak MA, Adeboye AA, Yusuf RA, Ghoniem ME. The Prospect of Lactoferrin Use as Adjunctive Agent in Management of SARS-CoV-2 Patients: A Randomized Pilot Study. Medicina (Kaunas) 2021;57:842. [PMID: 34441048 DOI: 10.3390/medicina57080842] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Li YQ, Guo C. A Review on Lactoferrin and Central Nervous System Diseases. Cells 2021;10:1810. [PMID: 34359979 DOI: 10.3390/cells10071810] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]